Literature DB >> 6204017

Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.

A M Palmer, N R Sims, D M Bowen, D Neary, J Palo, J Wikstrom, A N Davison.   

Abstract

Concentrations of 3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxy indoleacetic acid (5-HIAA) and homovanillic acid (HVA) were determined in lumbar cerebrospinal fluid (CSF) from control subjects and patients of both presenile and senile age with histologically verified Alzheimer's dementia. CSF HVA increased with age in control but not in Alzheimer patients. HVA and 5-HIAA in the CSF of presenile Alzheimer patients was lower than that of age matched control subjects.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6204017      PMCID： PMC1027823          DOI： 10.1136/jnnp.47.5.481

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  31 in total

1.  Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics.

Authors:  J M Coblentz; S Mattis; L H Zingesser; S S Kasoff; H M Wiśniewski; R Katzman
Journal:  Arch Neurol       Date:  1973-11

2.  Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).

Authors:  C G Gottfires; B E Roos
Journal:  Acta Psychiatr Scand       Date:  1973       Impact factor: 6.392

3.  Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex.

Authors:  C G Gottfries; I Gottfries; B Johansson; R Olsson; T Persson; B E Roos; R Sjöström
Journal:  Neuropharmacology       Date:  1971-11       Impact factor: 5.250

4.  Relationship of monoamine metabolites in human cerebrospinal fluid to age.

Authors:  M B Bowers; F A Gerbode
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

5.  Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid.

Authors:  G Curzon; E J Gumpert; D M Sharpe
Journal:  Nat New Biol       Date:  1971-06-09

6.  Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia.

Authors:  C G Gottfries; I Gottfries; B E Roos
Journal:  Acta Psychiatr Scand       Date:  1970       Impact factor: 6.392

7.  Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism.

Authors:  C G Gottfries; I Gottfries; B E Roos
Journal:  J Neurochem       Date:  1969-09       Impact factor: 5.372

8.  Acidic monoamine metabolites in cerebrospinal fluid of children with hydrocephalus.

Authors:  H Andersson; B E Roos
Journal:  Acta Neurol Scand Suppl       Date:  1965

9.  Amine metabolites in human cerebrospinal fluid: effects of cord transection and spinal fluid block.

Authors:  R M Post; F K Goodwin; E Gordon; D M Watkin
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

10.  Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid.

Authors:  E Garelis; T L Sourkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154
View more
  13 in total

Review 1.  The basis for behavioural disturbances in dementia.

Authors:  M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

2.  Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.

Authors:  G L Corona; M L Cucchi; P Frattini; G Santagostino; S Schinelli; A Romani; A Pola; F Zerbi; F Savoldi
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

3.  Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome.

Authors:  R Crols; J Saerens; M Noppe; A Lowenthal
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

4.  Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.

Authors:  Mary Gannon; Qin Wang
Journal:  Brain Res       Date:  2018-01-04       Impact factor: 3.252

5.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Serotonin2A receptor binding potential in people with aggressive and violent behaviour.

Authors:  Jeffrey H Meyer; Alan A Wilson; Pablo Rusjan; Michael Clark; Sylvain Houle; Scott Woodside; John Arrowood; Krystle Martin; Michael Colleton
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

Review 7.  Monoamine neurons in aging and Alzheimer's disease.

Authors:  A M Palmer; S T DeKosky
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease.

Authors:  M Tabaton; A Schenone; P Romagnoli; G L Mancardi
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

9.  Neuropsychological syndromes in presenile dementia due to cerebral atrophy.

Authors:  D Neary; J S Snowden; D M Bowen; N R Sims; D M Mann; J S Benton; B Northen; P O Yates; A N Davison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

10.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.